Australia Prefilled Syringes Market (2026-2031)
The Australia Prefilled Syringes Market was valued at $119.9 Million in 2026 and projected to reach to $195.8 Million by 2031, representing a compound annual growth rate of 10.3%. Australia's prefilled syringes market is poised for sustained growth through 2031, driven by increasing healthcare expenditure and the rising prevalence of chronic and autoimmune diseases requiring injectable treatments.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Australia Prefilled Syringes Market Trends and Insights
- This expansion reflects Australia's advancing healthcare infrastructure and increasing adoption of injectable biologics across therapeutic areas.
- Australia's pharmaceutical and biotechnology sectors are driving demand for prefilled syringes as healthcare providers prioritize patient safety, dosing accuracy, and operational efficiency in clinical settings. The Australian market benefits from strong regulatory frameworks, high healthcare spending, and growing prevalence of chronic diseases requiring injectable treatments.
- Australia's aging population and rising demand for self-administered therapies are accelerating prefilled syringe adoption among patients and healthcare facilities.
- Over the 2026–2031 forecast period, Australia is expected to maintain steady momentum, supported by innovation in drug delivery systems and expanding biopharmaceutical pipelines targeting Australian patients..
Key Market Statistics
- CAGR (2026-2031) 10.3% CAGR
- Market Size, 2026 ~USD 119.9 Million
- Forecast, 2031 ~USD 195.8 Million
- Country Australia
Australia Prefilled Syringes Market Overview
Market Valuation Growth :
Australia's prefilled syringes market is valued at USD 119.9 million in 2026, with strong momentum projected to reach USD 195.8 million by 2031, representing a 10.3% CAGR.
Healthcare Infrastructure Advancement :
Australia's robust healthcare system and advanced pharmaceutical infrastructure are driving adoption of prefilled syringes across hospitals, clinics, and specialty care centers nationwide.
Injectable Biologics Expansion :
Increasing prevalence of chronic diseases and growing demand for biologic therapies in Australia are accelerating the shift toward prefilled syringe delivery systems for improved patient outcomes.
Pharmaceutical Sector Leadership :
Australia's thriving pharmaceutical and biotechnology sectors are actively investing in prefilled syringe technology, positioning the country as a key market for innovative drug delivery solutions.
Australia Prefilled Syringes Market Dynamics
- The country's strong regulatory framework and emphasis on patient safety are accelerating the adoption of prefilled syringes over traditional vials and ampoules.
- Pharmaceutical manufacturers are expanding their product portfolios to meet growing demand from Australian healthcare providers and patients seeking convenient, accurate dosing solutions.
- Strategic partnerships between local distributors and international suppliers are enhancing market accessibility and driving competitive innovation in the region..
Related Ecosystem
Key Takeaways
- Australia's prefilled syringes market is valued at USD 119.9 million in 2026 and is forecast to grow to USD 195.8 million by 2031, representing a 10.3% CAGR.
- Australia's strong healthcare infrastructure and regulatory environment support widespread adoption of prefilled syringes across hospitals, clinics, and home-care settings.
- Rising chronic disease prevalence and an aging population in Australia are key drivers of demand for injectable therapies delivered via prefilled syringes.
- Australia's biopharmaceutical innovation and self-administration trends are expected to sustain market growth through 2031.
Prefilled Syringes Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | SAFETY PREFILLED SYRINGES (Type) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 10.9% from 2026 to 2031 |
| Largest Segment | CONVENTIONAL PREFILLED SYRINGES (Type) |
| Market Size Base Year (Billions) | ~USD 8.66 (2026) |
| Revenue Forecast (Billions) | ~USD 14.53 (2031) |
| Segments Covered | Type, Design, Material, Application |
Australia Prefilled Syringes Market Report Segmentation
4 segment dimensions are covered across the global market.
By Type
- Conventional Prefilled Syringes
- Disposable Prefilled Syringes
- Reusable Prefilled Syringes
- Safety Prefilled Syringes
By Design
- Customized Prefilled Syringes
- Dual-Chamber Prefilled Syringes
- Single-Chamber Prefilled Syringes
By Material
- Glass Prefilled Syringes
- Plastic Prefilled Syringes
By Application
- Anaphylaxis
- Cancer
- Diabetes
- Ophthalmology
- Other Applications
- Rheumatoid Arthritis
- Thrombosis
AUSTRALIA: PREFILLED SYRINGES MARKET, BY APPLICATION, 2024–2031
| Segment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ANAPHYLAXIS | 7.6 | 8.5 | 9.6 | 10.7 | 12.1 | 13.6 | 15.3 | 17.2 | 12.4 |
| CANCER | 30.5 | 34.7 | 39.5 | 45.1 | 51.4 | 58.6 | 66.8 | 76.2 | 14 |
| DIABETES | 27.6 | 30.4 | 33.5 | 36.9 | 40.7 | 44.8 | 49.4 | 54.4 | 10.2 |
| OPHTHALMOLOGY | 5.1 | 5.4 | 5.8 | 6.1 | 6.5 | 7 | 7.4 | 7.9 | 6.6 |
| OTHER APPLICATIONS | 11.9 | 13.2 | 14.7 | 16.4 | 18.4 | 20.5 | 22.9 | 25.5 | 11.6 |
| RHEUMATOID ARTHRITIS | 24.2 | 26.5 | 29 | 31.7 | 34.6 | 37.9 | 41.4 | 45.3 | 9.4 |
| THROMBOSIS | 9.5 | 10.3 | 11.2 | 12.1 | 13.1 | 14.2 | 15.4 | 16.7 | 8.3 |
| TOTAL | 116.3 | 129.1 | 143.2 | 159 | 176.7 | 196.5 | 218.5 | 243.2 | 11.2 |
Target Audience
- Pharmaceutical Manufacturers : Manufacturers need Australia-specific market data to develop product portfolios, set pricing strategies, and identify distribution channels aligned with local healthcare requirements and growth opportunities.
- Medical Device Companies : Device manufacturers require detailed Australian market insights to assess demand for prefilled syringe technologies, understand competitive positioning, and plan manufacturing or distribution investments.
- Healthcare Providers & Hospital Networks : Australian hospitals and clinics need market intelligence to evaluate prefilled syringe adoption trends, supplier options, and cost-benefit analyses for procurement and patient care optimization.
- Investors & Private Equity Firms : Investment professionals require Australia market data to evaluate acquisition targets, assess growth potential in the prefilled syringe sector, and make informed capital allocation decisions.
- Regulatory & Compliance Consultants : Consultants need Australia-specific regulatory and market insights to advise clients on compliance requirements, market entry strategies, and competitive positioning in the local healthcare ecosystem.
Key Companies in the Australia Prefilled Syringes Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| ATS AUTOMATION TOOLING SYSTEMS INC | Canada | Public Company | Conventional prefilled syringe automation,Safety prefilled syringe automation,Glass prefilled syringe–focused systems, |
| CONSORT MEDICAL | United Kingdom | Private Company | Conventional prefilled syringes,Safety prefilled syringes,Glass prefilled syringes, |
| HENRY SCHEIN | United States | Public Company | Conventional Prefilled Syringes,Safety Prefilled Syringes,Glass Prefilled Syringes, |
| FLUOR CORPORATION | United States | Public Company | Conventional Prefilled Syringe Infrastructure,Safety Prefilled Syringe Infrastructure,Glass Prefilled Syringe Facilities, |
| MERIT MEDICAL | United States | Public Company | Conventional Prefilled Syringes,Safety Prefilled Syringes,Glass Prefilled Syringes, |
| GUERBET GROUP | France | InvalidIdentifier | Conventional prefilled syringes,Safety prefilled syringes,Glass prefilled syringes, |
| BECTON, DICKINSON AND COMPANY (BD) | United States | ||
| GERRESHEIMER AG | Germany | Public Company | Conventional prefilled syringes,Safety prefilled syringes,Glass prefilled syringes, |
| SCHOTT | Germany | Public Company | Glass prefilled syringes (syriQ, syriQ BioPure, silicone-free),Polymer prefilled syringes (TOPPAC portfolio),Cartridges (cartriQ, dual-chamber, large volume), |
| WEST PHARMACEUTICAL SERVICES, INC. | United States | Public Company | Conventional prefilled syringes,Safety prefilled syringes,Glass prefilled syringe containment and components, |
| APTARGROUP, INC. | United States | Public Company | Conventional prefilled syringe components,Safety prefilled syringe and device-integrated systems,Glass prefilled syringe-related solutions, |
| NIPRO | Japan | Public Company | Glass Prefilled Syringe,Plastic Prefilled Syringe,Conventional Prefilled Syringe, |
| NOVARTIS AG | Switzerland | Public Company | Conventional Prefilled Syringes,Safety Prefilled Syringes,Glass Prefilled Syringe, |
| STEVANATO GROUP | Italy | Public Company | Conventional prefilled syringes,Safety prefilled syringes,Glass prefilled syringes, |
| POLYMEDICURE | India | Public Company | Conventional Prefilled Syringes,Safety Prefilled Syringes,Glass Prefilled Syringes, |
| SHARPS TECHNOLOGY, INC. | United States | Public Company | Conventional Prefilled Syringes,Safety Prefilled Syringes,Glass Prefilled Syringes, |
ATS AUTOMATION TOOLING SYSTEMS INC
ATS Automation Tooling Systems Inc is a Canadian public company founded in 1978 that employs 7,000 people. The company specializes in automation and tooling systems for industrial applications.
CONSORT MEDICAL
Consort Medical is a United Kingdom-based private company established in 1938 with 2,000 employees. The company operates in the medical devices and pharmaceutical sectors.
HENRY SCHEIN
Henry Schein is a United States public company founded in 1932 with 25,000 employees. The company is a distributor of healthcare products and services to dental, medical, and veterinary markets.
FLUOR CORPORATION
Fluor Corporation is a United States public company founded in 1912 with 22,995 employees. The company provides engineering, procurement, and construction services to the energy, chemicals, and infrastructure sectors.
MERIT MEDICAL
Merit Medical is a United States public company founded in 1987 with 7,500 employees. The company designs, manufactures, and distributes medical devices for interventional medicine and vascular access.
GUERBET GROUP
Guerbet Group is a French company in the medical imaging and pharmaceutical sectors. Specific operational details are unavailable.
BECTON, DICKINSON AND COMPANY (BD)
Becton, Dickinson and Company (BD) is a United States-based medical technology company. Specific founding date and employee count details are unavailable.
GERRESHEIMER AG
Gerresheimer AG is a German public company founded in 1864 with 13,528 employees. The company manufactures specialty glass and plastic products for the pharmaceutical and healthcare industries.
SCHOTT
Schott is a German public company founded in 1884 with 4,839 employees. The company produces specialty glass and glass-ceramic products for pharmaceutical, laboratory, and industrial applications.
WEST PHARMACEUTICAL SERVICES, INC.
West Pharmaceutical Services, Inc. is a United States public company founded in 1923 with 10,800 employees. The company manufactures packaging and delivery systems for injectable drugs and healthcare products.
APTARGROUP, INC.
AptarGroup, Inc. is a United States public company founded in 1992 with 14,000 employees. The company designs and manufactures dispensing systems and closures for the pharmaceutical, beauty, and food industries.
NIPRO
Nipro is a Japanese public company founded in 1947 with 38,593 employees. The company manufactures and distributes medical devices, pharmaceuticals, and healthcare products globally.
NOVARTIS AG
Novartis AG is a Swiss public company founded in 1996 with 75,267 employees. The company is a global pharmaceutical and healthcare company developing innovative medicines and treatments.
STEVANATO GROUP
Stevanato Group is an Italian public company founded in 1949 with 6,010 employees. The company manufactures glass and plastic packaging solutions for the pharmaceutical industry.
POLYMEDICURE
Polymedicure is an Indian public company founded in 1995 with 3,082 employees. The company manufactures and distributes medical devices and healthcare products.
SHARPS TECHNOLOGY, INC.
Sharps Technology, Inc. is a United States public company founded in 2017. Specific employee count details are unavailable.
Reasons to Buy this Report
- Market-Specific Sizing & Forecasts : Access precise valuation data for Australia's prefilled syringes market with detailed 2026-2031 projections, enabling accurate business planning and investment decisions tailored to the Australian market.
- Competitive Landscape Intelligence : Understand key players, market share distribution, and competitive strategies specific to Australia's pharmaceutical and biotech sectors to identify partnership and expansion opportunities.
- Regulatory & Healthcare Insights : Gain comprehensive understanding of Australia's regulatory environment, healthcare policies, and reimbursement frameworks that influence prefilled syringe adoption and market dynamics.
- Growth Driver Analysis : Identify specific factors driving Australia's 10.3% CAGR, including disease prevalence trends, healthcare infrastructure investments, and patient preference shifts toward injectable therapies.
- Strategic Market Entry Planning : Leverage Australia-focused market intelligence to develop targeted go-to-market strategies, distribution partnerships, and product positioning for successful market penetration and revenue growth.
Frequently asked questions
What is the current size of Australia's prefilled syringes market?
Australia's prefilled syringes market was valued at USD 119.9 million in 2026 and is expected to grow at a 10.3% CAGR through 2031.
What is the forecast market size for prefilled syringes in Australia by 2031?
Australia's prefilled syringes market is projected to reach USD 195.8 million by 2031, reflecting strong growth in injectable drug delivery adoption.
What factors are driving growth in Australia's prefilled syringes market?
Key drivers include Australia's aging population, rising chronic disease prevalence, strong healthcare infrastructure, regulatory support, and increasing demand for self-administered therapies.
How does Australia's prefilled syringes market compare to the Asia Pacific region?
Australia represents a significant segment within Asia Pacific, with its 10.3% CAGR reflecting mature healthcare systems and high adoption rates of advanced drug delivery technologies.
Which therapeutic areas are driving prefilled syringe demand in Australia?
Australia's demand is driven by biologics in oncology, immunology, rheumatology, and diabetes management, where injectable treatments and patient self-administration are increasingly prevalent.
RESEARCH METHODOLOGY
This study involved four major activities in estimating the current prefilled syringes market size. Exhaustive secondary research was done to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and sizing estimates with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments
Secondary Research
The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the prefilled syringes market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations operating in the prefilled syringes market. The primary sources from the demand side included industry experts, purchase & sales managers, doctors, and personnel from research organizations. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends and key market dynamics.
A breakdown of the primary respondents for the prefilled syringes market is provided below:
**Others include sales, marketing, and product managers.
Note 1: C-level executives include CEOs, COOs, and CTOs.
Note 2: Companies are classified into tiers based on their total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3 = <USD 500 million
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The research methodology used to estimate the size of the prefilled syringes market includes the following details.
The market sizing of the market was undertaken from the global side.
Country-level Analysis: The size of the prefilled syringes market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products and services in the overall prefilled syringes market was obtained from secondary data and validated by primary participants to arrive at the total prefilled syringes market. Primary participants further validated the numbers.
Geographic Market Assessment (By Region & Country): The geographic assessment was done using the following approaches:
Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends
Approach 2: Geographic adoption trends for individual product segments by prefilled syringes and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)
At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall prefilled syringes market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.
Prefilled Syringes Market : Top-Down and Bottom-Up Approach
Data Triangulation
After arriving at the overall market size—using the market size estimation processes explained above—the market was split into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Prefilled syringes are a convenient way to deliver parenteral medications or a single-dose packet of medication with a premeasured dose. This method of drug administration offers advantages for manufacturers in terms of reducing drug waste and extending product lifespan. Additionally, it provides ease of self-administration for patients at home and in non-hospital settings. Some examples of drugs packaged in prefilled syringes include biologics, vaccines, blood stimulants, therapeutic proteins, erythropoietin products, and interferons.
Key Stakeholders
- Product manufacturers, distributors, and suppliers
- Research laboratories
- Academic universities and medical research centers
- R&D centers
- Business research and consulting firms
- Biotechnology companies
- Hospitals
- Clinical centers
- Pharmaceutical companies
- Medical research laboratories
- Consulting firms
Report Objectives
- To describe, analyze, and forecast the prefilled syringes market by type, design, material, application, and region
- To describe and forecast the prefilled syringes market for key regions—North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries
- To provide detailed information regarding the drivers, restraints, opportunities, and challenges influencing the growth of the prefilled syringes market
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
- To profile key players and comprehensively analyze their market shares and core competencies in the prefilled syringes market
- To analyze competitive developments such as partnerships, collaborations, agreements & acquisitions, product launches, expansions, and R&D activities in the prefilled syringes market
Available customizations:
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
- Product matrix, which gives a detailed comparison of the product portfolio of each company
Geographic Analysis
- Further breakdown of the Rest of Europe prefilled syringes market into Belgium, Russia, the Netherlands, Switzerland, and other countries.
- Further breakdown of the Rest of Asia Pacific prefilled syringes market into Indonesia, Philippines, Vietnam, Hong Kong, and other countries
- Further breakdown of the Rest of Latin America prefilled syringes market into Colombia, Peru, and other countries.
Get the Full Prefilled Syringes Market Report
Full forecast, segment splits, and company analysis for all Prefilled Syringes Market.
- Canada Prefilled Syringes Market
- US Prefilled Syringes Market
- Germany Prefilled Syringes Market
- UK Prefilled Syringes Market
- France Prefilled Syringes Market
- Spain Prefilled Syringes Market
- Italy Prefilled Syringes Market
- Japan Prefilled Syringes Market
- China Prefilled Syringes Market
- India Prefilled Syringes Market
- South Korea Prefilled Syringes Market
- Brazil Prefilled Syringes Market
- Mexico Prefilled Syringes Market
- Argentina Prefilled Syringes Market
- GCC Countries Prefilled Syringes Market
- Rest Of Europe Prefilled Syringes Market
- Rest Of Asia Pacific Prefilled Syringes Market
- Rest Of Latin America Prefilled Syringes Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report